Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.
David Brousseau, MD, MS
Advertisement
David Brousseau, MD, MS, Pediatrician-in-chief, director of Research, Nemours Children’s Health
Articles by David Brousseau, MD, MS
Brousseau stressed that timeliness is not just guideline adherence, but it meaningfully changed whether children can go home from the ED, according to study results.
Advertisement
Latest Updated Articles
David Brousseau, MD: Benefits of timely opioid dosing for SCD painSeptember 12th 2025
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
3
Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa
4
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
5